Generic Portal

— Research Explorer

A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	100961
Pages (from-to)	100961
Journal	Cell Reports Medicine
Volume	4
Issue number	3
DOIs	https://doi.org/10.1016/j.xcrm.2023.100961 https://doi.org/10.1016/j.xcrm.2023.100961
Publication status	Published - 21 Mar 2023

acute myeloid leukemia, bispecific T cell engagers, CD1d, chronic lymphocytic leukemia, multiple myeloma, non-human primate, preclinical, single-domain antibody, type 1 NKT cell, Vγ9Vδ2-T cell

ID: 34667618